Nearly 3 years after findings from the Women’s Health Initiative
(WHI) threw a major wrench into menopausal hormone use, a panel convened by
the National Institutes of Health has taken a first step toward determining
safe, effective approaches in managing symptoms of menopause.
Panel chair Carol Mangione, MD, said confusion has flooded discussions
of managing menopausal symptoms since the WHI findings showed that estrogen
only and estrogen plus progestin therapy can increase the risk of coronary
heart disease, thromboembolism, stroke, and breast cancer.
Voelker R. NIH Panel Tries to Clear Confusion, Spur Research on Managing Menopause. JAMA. 2005;293(19):2329-2331. doi:10.1001/jama.293.19.2329